Allergan plc Goodwill

Allergan plc's goodwill stands at $41B as of March 2020. That compares with $43B in the prior-year period — down 4.9% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Allergan plc reported $41B in goodwill versus $43B a year earlier — a 4.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $43B in the prior-year period — down 4.9% year over year. Sustained growth in goodwill can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Allergan plc's goodwill evolved across reporting periods, while the comparison chart places AGN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, goodwill is commonly used to spot outliers. Allergan plc's reading of $41B is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.